SCHEMBL14545816

SCHEMBL14545816

C[C@H]1CCN(c2nc3c(-c4ccsc4)cnn3c(N)c2Br)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.45
▸ RAB9A P51151 4/20 0.45
▸ CHEK1 O14757 14/20 0.44
▸ CCNA2 P20248 13/20 0.44
▸ CDK2 P24941 13/20 0.44
▸ CCNA1 P78396 13/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ KDM4E B2RXH2 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ KDR P35968 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ LMNA P02545 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ CASP7 P55210 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11930783 0.89 CHEK1 (0.45) NPC1RAB9ACHEK1CCNA2CDK2
SCHEMBL14050871 0.80 NPC1 (0.40) NPC1RAB9ACHEK1CCNA2CDK2
SCHEMBL11930911 0.73 CHEK1 (0.57) CHEK1CCNA2CDK2CCNA1RPS6KA4
SCHEMBL12404064 0.72 CHEK1 (0.50) NPC1RAB9ACHEK1CCNA2CDK2
SCHEMBL11930796 0.71 CHEK1 (0.49) NPC1RAB9ACHEK1CCNA2CDK2
SCHEMBL14231848 0.70 CHEK1 (0.41) CHEK1CCNA2CDK2CCNA1RPS6KA4
SCHEMBL14539667 0.70 SMPD3 (0.41) NPC1RAB9ACHEK1CCNA2CDK2
SCHEMBL11930770 0.70 CHEK1 (0.73) CHEK1CCNA2CDK2CCNA1RPS6KA4
SCHEMBL14539665 0.69 CHEK1 (0.43) NPC1RAB9ACHEK1CCNA2CDK2
SCHEMBL14545940 0.69 SMPD3 (0.40) NPC1RAB9ACHEK1CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007044449-A2 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2007-04-19 — — WO disclosed
Send feedback